Evaxion AS (EVAX)
3.12
+0.04
(+1.30%)
USD |
NASDAQ |
Sep 04, 16:00
3.11
-0.01
(-0.32%)
After-Hours: 20:00
Evaxion SG&A Expense (TTM) : 4.527M for June 30, 2026
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical SG&A Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 4.527M |
| March 31, 2026 | 3.018M |
| December 31, 2025 | 1.491M |
| September 30, 2025 | 1.878M |
| June 30, 2025 | 4.018M |
| March 31, 2025 | 6.00M |
| December 31, 2024 | 7.607M |
| September 30, 2024 | 7.886M |
| June 30, 2024 | 8.662M |
| March 31, 2024 | 9.418M |
| December 31, 2023 | 10.36M |
| September 30, 2023 | 10.68M |
| June 30, 2023 | 9.768M |
| March 31, 2023 | 9.163M |
| Date | Value |
|---|---|
| December 31, 2022 | 8.201M |
| September 30, 2022 | 7.292M |
| June 30, 2022 | 6.777M |
| March 31, 2022 | 6.557M |
| December 31, 2021 | 6.244M |
| September 30, 2021 | 6.476M |
| June 30, 2021 | 6.730M |
| March 31, 2021 | 6.201M |
| December 31, 2020 | 4.922M |
| September 30, 2020 | 3.909M |
| June 30, 2020 | 2.165M |
| March 31, 2020 | 0.7815M |
| December 31, 2019 | 0.7815M |
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Autolus Therapeutics Plc | 152.92M |
| Cellectis SA | 21.32M |
| DBV Technologies SA | 56.62M |
| Ascendis Pharma A/S | 662.10M |
| Akari Therapeutics Plc | 8.796M |